Menu
Search

News

Swiss Deep Tech News & Analysis

Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.

Curated Newsfeed

See all news

DTN Highlights

See DTN Highlights

  • NovaGo Secures USD 30 Million to Advance Proof-of-Concept Study in Acute Spinal Cord Injury

    NovaGo Therapeutics AG, a clinical-stage biotechnology company, develops anti-Nogo-A biologics with the goal of delivering the first regenerative treatment for patients with acute spinal cord…

    startupticker.ch

    • NovaGo Therapeutics raised CHF 24 million to advance anti-Nogo-A antibody into proof-of-concept trial for acute spinal cord injury.
    • Lead program NG004 showed promising Phase 1 results and will be tested in randomized study enrolling 120 patients across Germany, Spain, and Switzerland.
    • NovaGo targets Nogo-A protein to enable nerve regeneration and restore neurological function in spinal cord injury patients.
    startupticker.ch: NovaGo Secures USD 30 Million to Advance Proof-of-Concept Study in Acute Spinal Cord Injury

  • Stryker acquires ZuriMED to enhance its shoulder offering

    Medical technology giant Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach…

    startupticker.ch

    • Stryker acquired ZuriMED, maker of the FiberLocker System for rotator cuff repair, which gained FDA clearance in February 2025.
    • FiberLocker System is soft tissue augmentation technology designed to reduce rotator cuff repair failures in sports medicine.
    • The acquisition strengthens Stryker's shoulder care portfolio across sports medicine and arthroplasty segments.
    startupticker.ch: Stryker acquires ZuriMED to enhance its shoulder offering

  • xorlab raises EUR 5 Million to build Europe’s sovereign email security platform

    Trusted by some of Europe's most demanding organizations across financial services, critical infrastructure, healthcare, and the public sector, xorlab is scaling rapidly as European enterprises…

    startupticker.ch

    • xorlab raised EUR 5M in Series A+ funding to expand its email security platform across DACH, Benelux, and Nordic regions.
    • The company uses behavioral AI to detect AI-crafted phishing and business email compromise attacks bypassing traditional filters.
    • European enterprises demand cybersecurity solutions with local data control, driven by regulations like DORA and NIS2.
    startupticker.ch: xorlab raises EUR 5 Million to build Europe’s sovereign email security platform

  • Swiss industrial company Bystronic acquires Isochronic

    Bystronic has entered into an agreement to acquire Isochronic AG, a Swiss automation technology company founded in 2020 and specializing in high-speed robotic sorting systems…

    startupticker.ch

    • Bystronic acquired Isochronic AG, a Swiss automation company specializing in high-speed robotic sorting systems for sheet metal processing.
    • Isochronic uses advanced robotic kinematics and proprietary software for automated material handling and sorting in laser cutting.
    • The acquisition combines Isochronic's robotics expertise with Bystronic's global reach and industrial knowledge for expanded automation.
    startupticker.ch: Swiss industrial company Bystronic acquires Isochronic

  • Adaptyv raises $40M to build automated lab for agentic biology

    Biopôle-based Adaptyv Biosystems just raised a $40M Series A to build the automated lab for agentic biology, The Swiss startup develops a protein engineering platform…

    startupticker.ch

    • Adaptyv Biosystems raised $40M Series A for AI-powered lab automation in protein engineering, targeting 3x capacity growth by end of 2026.
    • The company grew lab throughput 5x in one year and serves 100+ customers including Roche, Novo Nordisk, and AI biotech startups.
    • Adaptyv plans to expand into higher-value biology including developability, peptides, ADCs, and cell-based functions.
    startupticker.ch: Adaptyv raises $40M to build automated lab for agentic biology

  • Lookthrough acquires BuildingMinds from Schindler

    The transaction brings together two complementary businesses into one profitable AI software company serving institutional investors, governments and global technology companies, strengthening its position for…

    startupticker.ch

    • Lookthrough and BuildingMinds merged to create an AI platform covering 100,000+ buildings across 64 countries for institutional real estate.
    • The combined platform helps institutional investors shift from ESG compliance reporting to data-driven investment location decisions.
    • BuildingMinds keeps Berlin operations and brand while Schindler remains the largest shareholder of the new company.
    startupticker.ch: Lookthrough acquires BuildingMinds from Schindler

  • Gravis Robotics Raises $200M for Construction Autonomy

    Today, Gravis Robotics has officially announed a $200M investment from SoftBank Investment Advisers, the largest ever Series A raised in construction robotics history. With systems…

    startupticker.ch

    • Gravis Robotics raised $200M Series A from SoftBank, the largest construction robotics funding round, reaching $1B valuation.
    • Gravis' AI software works across mixed equipment fleets, delivering up to 30% productivity gains on construction jobsites.
    • The company uses simulated training data to teach machines autonomous excavation with precision in unpredictable soil conditions.
    startupticker.ch: Gravis Robotics Raises $200M for Construction Autonomy

  • Indivi attracts Infosys Innovation Fund as strategic investor

    Together with Infosys, Indivi aims to fundamentally unlock early-stage clinical development elevating tech-science at the epicenter of precision drug development in neurology. With its platform…

    startupticker.ch

    • Indivi's smartphone platform enables frequent assessment of motor and cognitive function to detect early treatment effects in neuroscience trials.
    • Infosys' investment helps Indivi scale its commercial organization and expand its digital biomarker platform across neuroscience programs.
    • Infosys and Indivi combine AI and machine learning with neuroscience expertise to accelerate drug development for Parkinson's and Alzheimer's.
    startupticker.ch: Indivi attracts Infosys Innovation Fund as strategic investor

  • Bruker makes minority investment in Atinary

    Bruker Corporation entered into an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs technologies and AI-driven R&D with applications in pharmaceuticals,…

    startupticker.ch

    • Bruker invested in Atinary to integrate analytical instruments, lab automation, and AI into Self-Driving Labs platforms.
    • Atinary's SDLabs platform automates Design-Make-Test-Analyze-Learn workflows using AI agents for faster discovery.
    • Demo labs in Basel and Boston integrate Chemspeed robotics, Bruker NMR, and Atinary's agentic AI technology.
    startupticker.ch: Bruker makes minority investment in Atinary

  • Boehringer Ingelheim acquires equine health startup Evax

    Boehringer Ingelheim has acquired Evax AG, a Swiss biotech company focused on therapeutic vaccines to address significant unmet needs in horses, particularly for the treatment of allergic…

    startupticker.ch

    • Boehringer Ingelheim acquired Swiss biotech Evax AG, which develops therapeutic vaccines using virus-like particles for allergic skin diseases in horses.
    • Evax's vaccine targets the root cause of equine allergies, offering longer-lasting relief than current shampoo and corticosteroid treatments.
    • The acquisition expands Boehringer Ingelheim's therapeutic vaccine portfolio for animal health, following its 2024 Saiba Animal Health acquisition.
    startupticker.ch: Boehringer Ingelheim acquires equine health startup Evax

  • London-based market intelligence company acquires Square Commodities

    FGE NexantECA has completed the acquisition of Morges-based Square Commodities ("SquareCo"), the leading research and data analytics platform specialising in the global renewable fuels market. Founded…

    startupticker.ch

    • FGE NexantECA acquired Square Commodities, a renewable fuels research platform, to enhance oil demand modeling with regulatory expertise.
    • Square Commodities will integrate into Lumen, FGE NexantECA's AI platform, to improve renewable fuels market analysis capabilities.
    • Founder Olivier Pellegrinelli will lead renewable fuels research, bringing over a decade of biofuels regulation and market experience.
    startupticker.ch: London-based market intelligence company acquires Square Commodities

  • Vaderis Therapeutics closes USD 152 million Series B Financing

    Basel-based Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on developing targeted therapies for rare vascular diseases, today announced the closing of a private $152 million…

    startupticker.ch

    • Vaderis raised $152M in Series B funding to advance engasertib into Phase 3 trials for hereditary hemorrhagic telangiectasia (HHT).
    • Engasertib, an oral AKT inhibitor, showed sustained improvements in HHT patients and could be the first approved HHT-specific therapy.
    • The HEROIC Phase 3 study is a global, randomized, placebo-controlled trial for moderate-to-severe HHT across three continents.
    startupticker.ch: Vaderis Therapeutics closes USD 152 million Series B Financing